COLLABORATION IS THE KEY
TO IMPROVING OUTCOMES
FOR CANCER PATIENTS
Join the CDDF community: working together to find ways to accelerate oncology drug development and deliver optimal treatment to cancer patients
The CDDF has developed a community of stakeholders who support the shared mission to facilitate debate and progress in the field of oncology drug development. Non-commercial organisations (academia, NGOs and associations), healthcare companies, regulatory agencies and patient groups involved in cancer research can become part of the collaborative CDDF network. The CDDF believes that collaboration plays a crucial role in overcoming challenges in the development of cancer drugs. By establishing the multi-stakeholder network and working together constructively, we can achieve our goal to increase efficiency in cancer drug development and accelerate the delivery of effective oncology treatment to patients.
We thank CDDF members and collaborators for their ongoing support.
REGULATORY AUTHORITIES
The CDDF collaborates with representatives from regulatory authorities to access their viewpoint on oncology drug development.
HEALTHCARE INDUSTRY MEMBERS
CDDF industry members provide the perspective of healthcare companies on challenges to be addressed in cancer drug development.
ORGANISATIONS
The CDDF collaborates closely with the following organisations whose missions are in alignment with the CDDF’s.
PATIENT ADVOCACY GROUPS
The CDDF works closely with patient advocacy groups to incorporate patient perspectives into discussions.
